Study: Statins Use After Prostate Cancer Surgery Lowers Cancer Recurrence

Study: Statins Use After Prostate Cancer Surgery Lowers Cancer RecurrenceAccording to researchers, males who use statins to lower their cholesterol level are 30% less likely to see their prostate cancer reappear after surgical procedure, as compared to males who do not make use of the drugs.

Boffins at Duke University Medical Centre also discovered that higher dosages of the drugs were linked with lower risk of reappearance.

RCom, RInfratel, GTL Sanction Rs 50K Crore Agreement

RCom, RInfratel, GTL Sanction Rs 50K Crore AgreementThe Boards of Reliance Communications Ltd. (RCOM), and its arm, Reliance Infratel Ltd and GTL Infrastructure Ltd today in-principle sanctioned a Rs 50,000 crore agreement to create the world's biggest independent telecommunication infrastructure company, neither owned nor controlled by any telecom operator.

In a declaration, , RCom stated that this transformational agreement will be implemented via a demerger of RINFRATEL's tower assets into GTL INFRA.

BHEL Sets Contribute 80% To Power Gen

BHEL Sets Contribute 80% To Power GenBharat Heavy Electricals Limited (BHEL) constructed thermal, hydro, gas and nuclear sets registered a record high generation of 490 Billion units of electricity in FY 2009-10.

Out of India's total generation by coal based utilities, BHEL sets have contributed a record 79.9%.

Mahindra Aerospace To Manufacture Smaller Aircraft For Indian Market

Mahindra Aerospace To Manufacture Smaller Aircraft For Indian MarketMahindra Aerospace of the $6.3-billion utility vehicle manufacturer Mahindra Group will become the first Indian private firm to make smaller civil aircraft for the Indian general aviation market, which is ready to flourish this decade. Mahindra Board Member Hemant Luthra said, "We will manufacture the turboprop aircraft in 2-20 seat capacity at our recently acquired Gippsland Aeronautics (GA) in Victoria State of Australia and market them in India."

Swapnil Compares His New Show 'Papad Pol' With ‘3 Idiots’

Swapnil Compares His New Show 'Papad Pol' With ‘3 Idiots’Well known TV actor Swapnil Joshi has compared his new serial "Papad Pol - Shahabuddin Rathod Ki Rangeen Duniya" with blockbuster movie "3 Idiots".

He also said that his new show will make the viewers laugh and cry simultaneously just like the Aamir-Bebo starrer.

Joshi plays the main character in the serial, which will hit TV screen on June 28.

RCom Surges 4.4% On GTL Deal

RCom Surges 4.4% On GTL DealThe scrip of Reliance Communications Ltd (RCom) was trading with healthy gains in noon, after rising dramatically during the morning on the week-end news of its $11-billion telcom tower agreement with GTL Infra.

The company's shares remained up by 4.36% at Rs. 200.90, around 1.30 p. m., as against its last closure at Rs 192.50. The scrip had shot up soon after opening bell to Rs 204.75.

Pages

News in Focus

Melbet, 4RABET, 1XBet, Rajabets Remain Popular Among Indian Bettors Despite Strict Rules; Cyrptocurrency used as Payment Option

Online cricket betting remains India's largest underground digital wager, even after New Delhi outlawed every form of real-money online gaming.

Bharat Dynamics Share Price Target at Rs 1,225: ICICI Securities

ICICI Securities has maintained its BUY rating on Bharat Dynamics with a 12-month target price of Rs 1,225, implying about 19% upside from the current market price of Rs 1,030.

L&T Finance Share Price Target at Rs 325: ICICI Securities

ICICI Securities has a BUY rating on L&T Finance with a 12-month target price of Rs 325, about 18% above the current market price of Rs 276. In a retail research note dated Nov.

Shriram Properties Share Price Target at Rs 110: ICICI Securities

ICICI Securities has maintained its BUY rating on Shriram Properties with a 12-month target price of Rs 110, about 53% above the current market price of Rs 72.

Max Estates Share Price Target at Rs 680: ICICI Direct

ICICI Securities has retained its BUY rating on Max Estates with a 12-month target price of Rs 680, implying about 34% upside from the current market price of Rs 509.